Daily Technical Summary Reports on Medical Supplies Stocks -- Insulet, Microbot Medical, C.R. Bard, and Hill Rom

NEW YORK, September 7, 2017 /PRNewswire/ --

If you want a Stock Review on PODD, MBOT, BCR, or HRC then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. Changing demographics, healthcare reform, and product innovation will shape the Medical Instruments and Supplies Manufacturing industry in coming years, as per an IBISWorld report. The aging population is expected to have the most significant effect on demand for medical supplies and instruments, as its need for care drives increases in overall public and private health expenditure. Ahead of today's trading session, DailyStockTracker.com has issued research reports on: Insulet Corp. (NASDAQ: PODD), Microbot Medical Inc. (NASDAQ: MBOT), C.R. Bard Inc. (NYSE: BCR), and Hill-Rom Holdings Inc. (NYSE: HRC). Register now and get full and free access to these DailyStockTracker.com research reports at:

http://dailystocktracker.com/register/

Insulet 

On Wednesday, shares in Billerica, Massachusetts headquartered Insulet Corp. recorded a trading volume of 223,448 shares. The stock ended at $58.61, rising 1.14% from the last trading session. The Company's shares have gained 8.78% in the last one month, 38.00% over the previous three months, and 55.55% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 10.59% and 31.76%, respectively. Furthermore, shares of Insulet, which develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the US and internationally, have a Relative Strength Index (RSI) of 68.32.  

On August 10^th, 2017, Insulet announced the appointments of Michael R. Minogue and James C. Mullen to its Board of Directors. The Company also announced that Regina Sommer and Joseph Zakrzewski have retired from its Board of Directors. Access our complete research report on PODD for free at:

http://dailystocktracker.com/registration/?symbol=PODD

Microbot Medical 

Yokneam, Israel-based Microbot Medical Inc.'s stock finished yesterday's session 6.00% higher at $1.06. A total volume of 1.31 million shares was traded, which was above their three months average volume of 947,010 shares. The Company's shares are trading below their 50-day moving average by 13.07%. Furthermore, shares of Microbot Medical, which engages in the research, design, development, and commercialization of micro-robotics medical technologies, have an RSI of 45.95.  

On August 14^th, 2017, Microbot Medical reported financial and operational results for the quarter and six months ended June 30^th, 2017. For Q2 2017, net loss was $3.5 million; R&D expenses were $0.37 million; and G&A expenses were $0.88 million. For the first half of the year, net loss was $4.8 million; R&D expenses were $0.56 million; and G&A expenses were $1.9 million. The complimentary research report on MBOT can be downloaded at:

http://dailystocktracker.com/registration/?symbol=MBOT

C.R. Bard 

At the close of trading on Wednesday, shares in Murray Hill, New Jersey headquartered C.R. Bard Inc. saw a slight drop of 0.17%, ending the day at $320.96. The stock recorded a trading volume of 316,097 shares. The Company's shares have advanced 0.63% in the last one month, 2.19% in the previous three months, and 42.86% since the start of this year. The stock is trading 0.52% and 17.71% above its 50-day and 200-day moving averages, respectively. Moreover, shares of C.R. Bard, which together with its subsidiaries, designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide, have an RSI of 56.41.  

On August 28^th, 2017, C.R. Bard announced that the LUTONIX® 035 Drug Coated Balloon PTA Catheter (DCB) has been granted premarket approval by the US FDA for a new indication and is now available for sale in the US. With this approval, the LUTONIX® 035 DCB Catheter becomes the first and only drug-coated balloon that is FDA approved as safe and effective in end-stage renal disease patients with stenotic lesions in dialysis arteriovenous fistulae. Register for free on DailyStockTracker.com and get access to the latest report on BCR at:

http://dailystocktracker.com/registration/?symbol=BCR

Hill-Rom Holdings 

Chicago, Illinois headquartered Hill-Rom Holdings Inc.'s shares ended the day 0.42% higher at $76.75 with a total trading volume of 365,141 shares. The stock has gained 1.09% in the last month and 36.71% on an YTD basis. The Company's shares are trading 10.73% above their 200-day moving average. Additionally, shares of Hill-Rom, which operates as a medical technology company worldwide, have an RSI of 54.81.  

On August 28^th, 2017, Hill-Rom announced that it will present at the Morgan Stanley Global Healthcare Conference on 11^th, 2017, in New York. John Greisch, President and CEO, is scheduled to present at 11:05 a.m. ET. Download your free research report on HRC at:

http://dailystocktracker.com/registration/?symbol=HRC

--

Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@dailystocktracker.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY 

DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

http://dailystocktracker.com/disclaimer/

CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: contact@dailystocktracker.com
Phone number: (207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE dailystocktracker.com